Clinical Study on Qingliang Huoxue Yin for Treatment of 68 Cases of Retinal Vein Obstruction of Blood Heat Stagnation Type

Wang Tongyun; Hong Yicheng; Chen Ruoxia; et al.

doi:10.13288/j.11-2166/r.2004.10.025

您当前的位置：

首页 >

文章列表页 >

Clinical Study on Qingliang Huoxue Yin for Treatment of 68 Cases of Retinal Vein Obstruction of Blood Heat Stagnation Type

更新时间：2021-11-22

- Clinical Study on Qingliang Huoxue Yin for Treatment of 68 Cases of Retinal Vein Obstruction of Blood Heat Stagnation Type
- Journal of Traditional Chinese Medicine Issue 10, Pages: 757-759(2004)
- 作者机构：
  
  1. 南京市中医院眼科中心检验科
  2. 南京市中医院眼科中心检验科江苏省南京市金陵路1号,210001
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2004.10.025
  CLC： R276.7
- Published：2004
- 稿件说明：
移动端阅览
[1]王彤云,洪宜成,陈若霞,钱朋寿,王贤勤.清凉活血饮治疗血热瘀阻型视网膜静脉阻塞68例临床研究[J].中医杂志,2004(10):757-759.

Wang Tongyun, Hong Yicheng, Chen Ruoxia, et al. Clinical Study on Qingliang Huoxue Yin for Treatment of 68 Cases of Retinal Vein Obstruction of Blood Heat Stagnation Type[J]. Journal of Traditional Chinese Medicine2004, (10): 757-759.
[1]王彤云,洪宜成,陈若霞,钱朋寿,王贤勤.清凉活血饮治疗血热瘀阻型视网膜静脉阻塞68例临床研究[J].中医杂志,2004(10):757-759. DOI： 10.13288/j.11-2166/r.2004.10.025.

Wang Tongyun, Hong Yicheng, Chen Ruoxia, et al. Clinical Study on Qingliang Huoxue Yin for Treatment of 68 Cases of Retinal Vein Obstruction of Blood Heat Stagnation Type[J]. Journal of Traditional Chinese Medicine2004, (10): 757-759. DOI： 10.13288/j.11-2166/r.2004.10.025.

摘要

目的:观察清凉活血饮治疗血热瘀阻型视网膜静脉阻塞（RVO）的疗效及作用机理。方法:对眼底荧光血管造影（FFA）确诊为RVO的患者进行中医辨证

将血热瘀阻型患者随机分为两组

治疗组68例给予自拟清凉活血饮口服

对照组30例给予脉络宁静脉滴注

观察两组的临床疗效及治疗组治疗前后血液流变学、血浆组织型纤溶酶原激活剂（T-PA）和纤溶酶原激活剂抑制物（PAI）活性的变化。结果:治疗组总有效率为80.9%

优于对照组（P<0.05）。治疗组治疗后血液流变学明显改善

血浆T-PA明显上升

PAI明显下降

明显优于治疗前（P<0.01）。结论:清凉活血饮具有降低血液粘稠度、调节机体纤溶系统功能的作用

治疗血热瘀阻型RVO效果较好。

Abstract

Objective: To observe therapeutic effect of Qingliang Huoxue Yin on retinal vein obstruction（RVO） of blood heat stagnation type. Methods: The patients of RVO were definitely diagnosed by fundus fluorescein angiography（FFA）. Among them

the patients of blood heat stagnation type were randomly divided into a treatment group（n=68） treated by self-stipulated Qingliang Huoxue Yin and a control group（n=30） treated by intravenous drip of Mailuoning. Clinical therapeutic effects of the two groups and changes of hemorhologic indexes

and plasma tissue type plasminogen activator （T-PA） and plasminogen activator inhibitor（PAl） activities after treatment in the treatment group were investigated. Results: The total effective rate was 80.9% in the treatment group. superior to the control group （P<0.05）

and after treatment the hemorhelogic indexes improved and plasma T-PA increased and PAI decreased significantly in the treatment group

superior to that before treatment （P<0.01）. Conclusion: Qingliang Huoxue Yin has a better therapeutic effects for the patient of RVO of blood heat stagnation type.

关键词

Keywords

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Similarities and Differences between Myofascial Trigger Points and Sinew Knot：from the Perspective of the Channel Sinew Theory

Construction and Application of "Source-Pivot-Convergence" Pattern Identification and Treatment Model for Malignant Tumors

Challenges and Recommendations for Implementing Key Technologies in Decentralized Clinical Trials of Traditional Chinese Medicine

Differentiation and Treatment of Small Cell Lung Cancer from the Perspective of "Internal Wind in Hidden Circulation"

Effect of Tongbian Decoction （通便汤） on the VAPB-PTPIP51 Complex and Autophagy of Interstitial Cells of Cajal in the Colon of Slow Transit Constipation Model Rats

Related Author

No data

Related Institution

No data

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰